Page 30 - General Brigham News Today : Breaking News, Live Updates & Top Stories | Vimarsana

<p>A new study by investigators from <a href="https://www.massgeneralbrigham.org/">Mass General Brigham</a> found that one in five individuals taking Nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19, experienced a positive test result and shedding of live and potentially contagious virus following an initial recovery and negative test&mdash;a phenomenon known as virologic rebound. By contrast, people not taking Paxlovid only experienced rebound about 2 percent of the time. Results are published in <a href="...

Healthcare

Mass General Brigham is offering buyouts to its digital employees as it adjusts to changes in care delivery and technology.

Mass General Brigham has told Digital employees that it's offering buyouts, as the health care behemoth called it a "difficult decision" to cut down its workforce.

Mass General Brigham plans to offer $470 million in bonds in January to finance capital projects and refinance debt. The system is progressing with a $2 billion expansion plan.